2008
DOI: 10.1089/hum.2007.141
|View full text |Cite
|
Sign up to set email alerts
|

Radioprotection In Vitro and In Vivo by Minicircle Plasmid Carrying the Human Manganese Superoxide Dismutase Transgene

Abstract: Manganese superoxide dismutase-plasmid liposomes (MnSOD-PL) confer organ specific in vivo ionizing irradiation protection. To prepare for potential intravenous clinical trials of systemic MnSOD-PL for radioprotection in humans, plasmid and bacterial sequences were removed and a new mini circle construct was tested. Mini circle-MnSOD was purified and then co-transfected into 32D cl 3 murine IL-3 dependent hematopoietic progenitor cells along with another plasmid containing the neo gene. Cells were selected in G… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
36
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(36 citation statements)
references
References 23 publications
0
36
0
Order By: Relevance
“…Third, minicircle DNA vectors achieve sustained expression reflected by active chromatin and the transcriptional level (54). The robust and persistent gene expression delivered by minicircle DNA has been shown in vitro and in vivo (14,15,20,37,55). Because of this, we hypothesized that minicircle DNA may be an attractive plat- form for DNA vaccine.…”
Section: Discussionmentioning
confidence: 99%
“…Third, minicircle DNA vectors achieve sustained expression reflected by active chromatin and the transcriptional level (54). The robust and persistent gene expression delivered by minicircle DNA has been shown in vitro and in vivo (14,15,20,37,55). Because of this, we hypothesized that minicircle DNA may be an attractive plat- form for DNA vaccine.…”
Section: Discussionmentioning
confidence: 99%
“…6,7 Meanwhile, MnSOD was shown to provide significant radioprotection to cultured cells in vitro as well as some tissues in vivo. 25 In order to investigate the potential for possible clinical therapies, we previously generated a MnSOD plasmid and lipofectin complex (MnSOD-PL), 26,27 which was a FDA-approved therapeutic agent being evaluated in a phase I/II trial for radioprotection of patients with non-small cell lung cancer, 28,29 to target specific tissues or cells.…”
Section: Introductionmentioning
confidence: 99%
“…Overexpression of MnSOD through the use of minicircle DNA containing the human MnSOD transgene has been shown to protect against ionizing irradiation both in vitro and in vivo (Zhang et al, 2008). In addition, up-regulation of MnSOD expression enhanced the radiosensitivity in rat fibrosarcoma cells (Urano et al, 1995).…”
Section: Discussionmentioning
confidence: 99%